{
    "title": "105_s1599",
    "content": "The \"Human Cloning Prohibition Act of 1998\" prohibits the creation of cloned human embryos for research purposes. This Act is added to Title 18 of the United States Code as \"CHAPTER 16--CLONING.\" The \"Human Cloning Prohibition Act of 1998\" prohibits the use of human somatic cell nuclear transfer technology, including importing embryos produced through this technology. Violators may face fines, imprisonment, or both. The \"Human Cloning Prohibition Act of 1998\" imposes civil penalties for violations involving pecuniary gain, with fines up to double the gross gain. The Act defines human somatic cell nuclear transfer technology as creating embryos using human somatic cell nuclear material. SEC. 4. COMMISSION TO PROMOTE A NATIONAL DIALOGUE ON BIOETHICS. The National Commission to Promote a National Dialogue on Bioethics is established within the Institute of Medicine with 25 members appointed by Senate and House leaders, with one member serving as the Chairperson. The National Commission on Bioethics, established with 25 members appointed by Senate and House leaders, must ensure diverse representation from fields such as law, theology, medicine, science, and society. Members must be appointed by December 1, 1998, and serve a 3-year term without consecutive reappointments. The National Commission on Bioethics has 25 members appointed by Senate and House leaders from various fields. Members serve a 3-year term without consecutive reappointments. The Commission meets at the call of its Chairperson or majority, with a quorum of 13 members. Vacancies are filled promptly, and members receive travel expenses and per diem but no additional pay or benefits. The National Commission on Bioethics, established in accordance with sections 5702 and 5703 of title 5, United States Code, provides a forum for public discourse on bioethical issues like cloning. The Commission's duties include reporting to Congress on findings and recommendations for Federal policy. The Chairperson can appoint staff without regard to civil service laws, who will support the Commission's work. The National Commission on Bioethics, established under title 5, United States Code, can procure temporary services and office space through the General Services Administration for its headquarters. The Commission has the power to conduct hearings and other activities related to bioethical issues. The National Commission on Bioethics can hold public hearings and request federal agency personnel for assistance without affecting their civil service status. Federal agencies must provide technical assistance as requested by the Commission. The National Commission on Bioethics can request technical assistance from federal agencies and obtain necessary information directly from them. The Commission may use the United States mails and receive administrative support services as needed. The National Commission on Bioethics can request administrative support services from the Administrator of General Services on a reimbursable basis. The Commission shall establish 6 subcommittees to address various issues including legal, theological, philosophical, ethical, medical, and scientific issues. The National Commission on Bioethics shall establish 6 subcommittees, including a subcommittee on scientific issues and a subcommittee on social issues. Each subcommittee will have specific membership requirements, including experts appointed by different members of the Committee. The National Commission on Bioethics will establish 6 subcommittees, with specific membership requirements including individuals from the private sector and experts appointed by different Committee members. The subcommittees' meetings will be approved by the Commission, and a report with recommendations will be submitted to Congress annually. Authorization of appropriations is provided for the implementation of this section. SEC. 5 of the Act ensures unrestricted scientific research not prohibited by the Act. SEC. 6 expresses Congress's support for an international ban on using human somatic cell nuclear transfer technology to create human embryos."
}